Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass

NCT05101746 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Disease
Congenital Heart Defect
Congenital Heart Malformations

Interventions

DRUG: Nitric Oxide (NO) 20 part per million (ppm)
OTHER: Standard of care cardiopulmonary bypass

Sponsor

Vanderbilt University Medical Center